
Sign up to save your podcasts
Or


While the science is still in its early stages, the hardest part about developing a super-vaccine for all coronaviruses could be finding a way to pay for it.
Bloomberg Businessweek's Mark Leydorf reads, "The Hunt for a Single Shot to Defeat Omicron and All Coronaviruses" by Robert Langreth.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
See omnystudio.com/listener for privacy information.
By Bloomberg and iHeartPodcastsWhile the science is still in its early stages, the hardest part about developing a super-vaccine for all coronaviruses could be finding a way to pay for it.
Bloomberg Businessweek's Mark Leydorf reads, "The Hunt for a Single Shot to Defeat Omicron and All Coronaviruses" by Robert Langreth.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
See omnystudio.com/listener for privacy information.